140 related articles for article (PubMed ID: 7900978)
1. [Establishment of the multidrug-resistant cell line K562/A02 and its drug-resistant properties].
Luan FJ
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):101-3. PubMed ID: 7900978
[TBL] [Abstract][Full Text] [Related]
2. [Study on the reversing effect of tripiperaquine on human multidrug resistant leukemic cell line K562/A02].
Yang R; Yang C; Hao Y
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):340-2. PubMed ID: 8697970
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
5. [Reduced intracellular drug accumulation related to overexpression of P-glycoprotein cannot explain the complete drug resistance in MDR cell variant K562/Dox].
Hu X; Pan Q; Zheng S
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):85-8. PubMed ID: 7656812
[TBL] [Abstract][Full Text] [Related]
6. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
7. Selection of a new multidrug resistant cell line from Friend leukemia cells by short and cyclic exposures to high concentrations of daunorubicin.
Abbadessa V; Tolomeo M; Luparello M; Perricone R; Cajozzo A; Dusonchet L; Candiloro V; Crosta L; Rausa L
Haematologica; 1992; 77(2):137-41. PubMed ID: 1356894
[TBL] [Abstract][Full Text] [Related]
8. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
9. Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphonates.
Vasanthakumar G; Ahmed NK
Cancer Commun; 1989; 1(4):225-32. PubMed ID: 2576974
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a K562 multidrug-resistant cell line.
Yanovich S; Hall RE; Gewirtz DA
Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
[TBL] [Abstract][Full Text] [Related]
11. MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine.
Russo D; Michelutti A; Melli C; Damiani D; Michieli MG; Candoni A; Zhou DC; Marie JP; Zittoun R; Baccarani M
Leukemia; 1995 Mar; 9(3):513-6. PubMed ID: 7885049
[TBL] [Abstract][Full Text] [Related]
12. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
[TBL] [Abstract][Full Text] [Related]
14. [Induction of anti-leukemic immunity of dendritic cells derived from multidrug resistant leukemia K562/A02 cells with high expression of P-glycoprotein and sensitive K562 cells].
Zhang YM; Zhang LS; Zhang YF; Yi LC; Chai Y; Song FX; Zeng PY; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1018-22. PubMed ID: 16403271
[TBL] [Abstract][Full Text] [Related]
15. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
[TBL] [Abstract][Full Text] [Related]
16. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTĪ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
17. [2 homoharringtonine resistant leukemic cell lines (K562 HHT and L1210 HHT): establishment, characterization and mechanisms of action].
Han JL; Yan WW; Qian QJ
Zhonghua Yi Xue Za Zhi; 1994 Jul; 74(7):424-7, 456. PubMed ID: 7987716
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Compound Zhebei Granule plus doxorubicin on mdr 1 gene expression in nude mice with K562/A02 tumor xenografts].
Zheng Z; Chen J; Li DY; Chen XY
Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):758-62. PubMed ID: 19671415
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
